FDA authorizes the first AI-driven MRI solution for safer Alzheimer’s treatment

BOSTON and LEUVEN, Belgium, Nov. 14, 2024 /PRNewswire/ — Why this news will impact the lives of people affected by Alzheimer’s disease: The first disease-modifying therapies for Alzheimer’s disease have come to the market over the previous years – providing hope to the millions affected…